Pindolol in the treatment of arterial hypertension
Strozzi, C.; Cocco, G.
Minerva Medica 69(4): 247-256
1978
ISSN/ISBN: 0026-4806 PMID: 342988 Document Number: 135883
Document emailed within 1 workday
Related Documents
Gruppillo, P.; Padovan, G.C.; Masoni, C.; Tomaini, M.D. 1982: Use of pindolol in a once-a-day dose in the treatment of arterial hypertension La Clinica Terapeutica 100(2): 167-174Ciaramelli, F. 1978: Single daily dose of pindolol in the treatment of arterial hypertension La Nouvelle Presse Medicale 7(31): 2761-2764
Gross-Sawicka, E.; Wyrzykowski, B.; Krupa-Wojciechowska, B. 1988: Effect of pindolol treatment on left-ventricular systolic and diastolic time intervals in men with borderline primary arterial hypertension Polski Tygodnik Lekarski 43(27): 880-884
Gross-Sawicka, E.; Wyrzykowski, B.; Krupa-Wojciechowska, B. 1988: Effect of the treatment with pindolol and clopamide on left-ventricular systolic and diastolic time intervals in patients with moderate primary arterial hypertension Polski Tygodnik Lekarski 43(27): 885-888
De Ferrari, G.; Gaiter, A.; Ginevri, F.; Tizianello, A. 1979: Effects of pindolol on arterial pressure and plasma renin activity in essential hypertension and in hypertension during chronic renal insufficiency La Clinica Terapeutica 90(5): 461-468
Zilenovski, A.M.; Freire, C.A. 1981: Effect of the combination of Pindolol and clopamide in systemic arterial hypertension. a multicenter study Arquivos Brasileiros de Cardiologia 37(3): 219-224
Frithz, G. 1975: Pindolol once daily in the treatment of hypertension Lakartidningen 72(33): 3073-3074
Seedat, Y.K.; Rawat, R. 1984: A dose-finding study of the combination of pindolol, clopamide and endralazine in the treatment of moderate-to-severe hypertension South African Medical Journal 66(18): 682-684
Mikunis, R.I.; Monastyrskiĭ, I.I.; Pshelutskiĭ, F.F.; Serkova, V.K.; Demidiuk, V.T. 1988: Use of foridon in the treatment of arterial hypertension and hypertension of the lesser circulation Kardiologiia 28(12): 51-53
Pellegrino, L.; Prencipe, G. 1995: Ultrasonography of the carotid arteries in mild-to-moderate essential arterial hypertension and isolated systolic arterial hypertension Cardiologia 40(2): 109-116
Borovkov, N.N.; Sidorova, N.V. 2002: 24-hour arterial hypertension profile and heart rhythm variability in patients with arterial hypertension and NIDDM Klinicheskaia Meditsina 80(7): 19-21
Magliano, M.F.; Amodeo, C.; Mion Júnior, D.; Francischetti, E.; Lima Júnior, E.; Nobre, F.; Chaves, H.; Ribeiro, J.M.; Spritzer, N.; Jardim, P.C. 1993: A Brazilian multicenter study to evaluate the clinical effectiveness and tolerance of isradipine SRO using ambulatory monitoring of arterial pressure in the treatment of mild and moderate arterial hypertension Arquivos Brasileiros de Cardiologia 61(5): 311-318
Metelitsa, V.I.; Filatova, N.P. 1991: The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension. I. The research protocol and results of monotherapy Terapevticheskii Arkhiv 63(8): 30-34
Cloix, J.F.; Devynck, M.A.; Meyer, P. 1982: Plasma protein changes in essential arterial hypertension: a new genetic marker for arterial hypertension? Annales de Pediatrie 29(9): 655-656
Debru, J.L.; Mikler, F.; Grubier, M.; Cau, G.; Muller, J.M.; Mallion, J.M. 1976: Study of the action of pindolol during rest and exertion on a group of subjects with hypertension Annales de Cardiologie et d'Angeiologie 25(5): 393-397
Frewin, D.B.; Penhall, R.K.; Leonello, P.P.; Clapp, R.J. 1980: Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol New Zealand Medical Journal 92(672): 389-390
Batyraliev, T.A.; Makhmutkhodzhaev, S.A.; Ekinsi, E.; Pataraia, S.A.; Pershukov, I.V.; Sidorenko, B.A.; Preobrazhenskiĭ, D.V. 2007: Pulmonary hypertension and right ventricular failure. Part XI. Endothelin receptor blockers in the treatment of primary pulmonary arterial hypertension Kardiologiia 47(7): 73-82
England, J.D. 1981: Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol Australian and New Zealand Journal of Medicine 11(1): 35-40
Andréjak, M.; Zannad, Fïez.; Laville, M.; Duru, Gérard.; Mourad, J-Jacques.; Waeber, B. 2003: Evaluation of different approaches to the treatment of arterial hypertension: combination treatment with low dose perindopril/indapamide versus sequential treatment of stepped-dose treatment Therapie 58(4): 351-352
De Micheli, A.; Cordera, R.; Maiello, M.; Odetti, P.; Viviani, G.; Boeri, D.; Prando, R. 1979: Effects of pindolol on insulin secretion. I. Insulin response to small intravenous loads of glucose and to pindolol infusion Minerva Dietologica E Gastroenterologica 25(3): 297-304